EndoSound

• ·Developer of an ultrasound imaging system designed to cater to gastrointestinal patient care with a fully functional endoscopic ultrasound (EUS) scope.
• ·EndoSound is valued at approximately $24.5M as of Oct 2026 (last reported valuation).
• ·It has raised $8.5M across 4 recorded rounds; the latest was Seed Round ($250K) in Jun 2026.
• ·Notable investors include GEO MedTech Ventures, American Gastroenterological Association, Oregon Bioscience Incubator, Varia Ventures.
• ·EndoSound has filed 5 Form Ds with the SEC since 2021, most recently Aug 2025 ($1.9M sold to 10 investors).
• ·Status: Privately Held (backing).

Developer of an ultrasound imaging system designed to cater to gastrointestinal patient care with a fully functional endoscopic ultrasound (EUS) scope. The company's system offers an adaptive design that allows providers to easily convert existing flexible video gastroscopes from the major endoscope manufacturers into ultrasound endoscopes at a fraction of the cost integrates into hospitals and ASCs of any size or location, and serves as a tool in the diagnosis and treatment of a wide variety of benign and malignant disorders of the digestive tract, most prominently those of the pancreas, enabling patients and physicians to get access to EUS while reducing overall health care costs.

Sector

Healthcare

HQ

Portland, OR, United States

Founded

2016

Employees

14

Website

endosound.com/

Ownership

Privately Held (backing)